30M Genomics Private Limited - Company Profile

It is a non-profit organizations private limited company based in West Godavari District, Andhra Pradesh, India, established in 2019.
2019 West Godavari District, Andhra Pradesh, India Active
Last Updated:
Access Report
About 30M Genomics Private Limited

30M Genomics Private Limited, a active private limited company, was established on 18 July 2019 in West Godavari District, Andhra Pradesh, India. Engaging in social work within the hospital and medical care sector, it holds CIN: U85300AP2019PTC112451. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹1.60 M and a paid-up capital of ₹0.12 M.

Its leadership includes Benet Bosco Dhas (Director), Sasikanta Naga Pavani Pavuluri (Director). Past directors included Yaswanth Reddy. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at C/O Pavuluri Lakshmana Rao, Near Church Pavulavarigudem, Dwarakatirumala,, West Godavari District, Andhra Pradesh, 534426.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85300AP2019PTC112451

  • Registration Number

    112451

  • Incorporation Date

    18 July 2019

  • Authorized Capital

    ₹1.60 M

  • Paid-Up Capital

    ₹0.12 M

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.60 M
  • Paid Up Capital ₹ 0.12 M
  • Company Age 6 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 584.40%
  • Profit Growth **** -45.96%
  • Ebitda **** -316.13%
  • Net Worth 2173.52%
  • Total Assets **** 202.43%
Company report

30M Genomics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into 30M Genomics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at 30M Genomics Private Limited?
Current Directors
Name Designation Appointment Date Status
Benet Bosco Dhas Director 18 Jul 2019 Current
Sasikanta Naga Pavani Pavuluri Director 18 Jul 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 20 Apr 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of 30M Genomics.

30M Genomics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 584.4% increase. The company also saw a substantial fall in profitability, with a 45.96% decrease in profit. The company's net worth Soared by an impressive increase of 2173.52%.

30M Genomics revenue growth over time
30M Genomics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 584.40%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 202.43%
*******
*******
*******
*******
Profit or Loss
*******
 -45.96%
*******
*******
*******
*******
Net Worth
*******
 2173.52%
*******
*******
*******
*******
EBITDA
*******
 -316.13%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of 30M Genomics?

In 2022, 30M Genomics had a public holding of 4.76%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at 30M Genomics?

Unlock and access historical data on people associated with 30M Genomics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of 30M Genomics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped 30M Genomics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on 30M Genomics
Recent Activity within the Organization
  • Annual General Meeting

    30M Genomics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity 30M Genomics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada. was completed.

  • Director Appointment

    The activity Benet Bosco Dhas was appointed as a Director was appointed as a Director on 18 Jul 2019 & has been associated with this company since 6 years 7 months . was completed.

  • Director Appointment

    Progress on Sasikanta Naga Pavani Pavuluri was appointed as a Director was appointed as a Director on 18 Jul 2019 & has been associated with this company since 6 years 7 months . was documented.

  • Company Incorporation

    30M Genomics Private Limited was registered on 18 Jul 2019 with Roc Vijayawada & aged 6 years 7 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of 30M Genomics Private Limited?

The CIN of 30M Genomics Private Limited is U85300AP2019PTC112451.

Where is 30M Genomics Private Limited headquartered?

30M Genomics Private Limited is headquartered at C/O Pavuluri Lakshmana Rao, Near Church Pavulavarigudem, Dwarakatirumala,, West Godavari District, Andhra Pradesh, 534426.

When was 30M Genomics Private Limited incorporated?

30M Genomics Private Limited was incorporated on 18 July 2019.

Who are the current directors of 30M Genomics Private Limited?

The current directors of 30M Genomics Private Limited are

What is the primary industry of 30M Genomics Private Limited?

The primary industry of 30M Genomics Private Limited is Hospital And Medical Care.

Is 30M Genomics Private Limited a listed company?

30M Genomics Private Limited is unlisted.

What is the capital structure of 30M Genomics Private Limited?

The authorized capital of 30M Genomics Private Limited is ₹1.60 M, and the paid-up capital is ₹0.12 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available